| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $75.4M | +644.9% |
| Cost of Revenue | $96.4M | +746.3% |
| R&D Expense | $117.7M | -15.0% |
| SG&A Expense | $131.9M | +30.5% |
| Operating Income | -$270.5M | -12.1% |
| Interest Expense | $36.7M | +294.6% |
| Pre-tax Income | -$285.6M | -30.3% |
| Income Tax | $2.0M | +29.1% |
| Net Income | -$287.5M | -30.3% |
| EPS (Basic) | -$1.08 | -25.6% |
| EPS (Diluted) | -$1.08 | -25.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $104.1M | -54.2% |
| Accounts Receivable | $24.0M | — |
| Inventory | $33.2M | +702.5% |
| Current Assets | $435.9M | -34.0% |
| Total Assets | $589.1M | -24.7% |
| Current Liabilities | $73.4M | +20.9% |
| Total Liabilities | $410.9M | +15.6% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$283.6M | -37.5% |
| Capital Expenditures | $19.0M | -13.7% |
| Investing Cash Flow | $158.5M | +140.2% |
| Financing Cash Flow | -$4.3M | -100.7% |
| Free Cash Flow | -$302.6M | -32.5% |
| $178.1M |
| -58.3% |